Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Immunocept LLC

This article was originally published in Start Up

Executive Summary

Immunocept hopes its device approach to sepsis will succeed where drugs have failed. It has developed a large pore filter for an extracorporeal device that filters out unwanted mediators of sepsis from the blood, and returns blood back to the patient.
Advertisement

Related Content

Liver Roll-Ups? (Not the Deli Kind)
Liver Assist Devices: Proof of Life
Liver Assist Devices: Proof of Life
Protein C: Saving Lives, Saving Lilly
Protein C: Saving Lives, Saving Lilly

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

MT037205

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel